AlphaCentric Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.11M | Buy |
+19,649
| New | +$1.11M | 1.11% | 24 |
|
|
2023
Q4 | – | Sell |
-3,153
| Closed | -$183K | – | 234 |
|
|
2023
Q3 | $183K | Sell |
3,153
-95
| -3% | -$5.51K | 0.1% | 156 |
|
|
2023
Q2 | $208K | Sell |
3,248
-231
| -7% | -$14.8K | 0.12% | 146 |
|
|
2023
Q1 | $241K | Sell |
3,479
-39
| -1% | -$2.7K | 0.17% | 132 |
|
|
2022
Q4 | $253K | Buy |
+3,518
| New | +$253K | 0.25% | 121 |
|
|
2021
Q4 | $748K | Buy |
12,000
+11,290
| +1,590% | +$704K | 0.22% | 47 |
|
|
2021
Q3 | $42K | Hold |
710
| – | – | 0.01% | 192 |
|
|
2021
Q2 | $47K | Hold |
710
| – | – | 0.01% | 202 |
|
|
2021
Q1 | $45K | Hold |
710
| – | – | 0.02% | 196 |
|
|
2020
Q4 | $44K | Hold |
710
| – | – | 0.02% | 187 |
|
|
2020
Q3 | $43K | Hold |
710
| – | – | 0.02% | 117 |
|
|
2020
Q2 | $42K | Buy |
+710
| New | +$42K | 0.02% | 93 |
|